Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
MRSH compared with AZN: revenue, margins and what each company keeps, and the suppliers and customers both name
MRSH
Marsh & McLennan Companies, Inc.
Change
Mkt cap
Revenue
Revenue
AZN
Astrazeneca PLC
Change
Mkt cap
Revenue
Revenue
vs
Compare
MRSH
Marsh & McLennan Companies, Inc.
vs
AZN
Astrazeneca PLC
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only MRSH
0
None
Shared
0
No disclosed counterparties: MRSH.
Only AZN
20
ARQT
Arcutis Biotherapeutics
customer
GRAL
Grail
supplier
RCUS
Arcus Biosciences
customer
NKTR
Nektar Therapeutics
supplier
16 more · AZN chain
›
Role chip = supplier or customer
Source: SEC EDGAR
MRSH
Marsh & McLennan Companies, Inc.
Change
204.94
▼
−2.14%
· post 204.20
Mkt cap
$97.4B
Revenue
$6.6B
Q3 FY26
Revenue
$26.1B
FY25
AZN
Astrazeneca PLC
Change
186.20
▼
−0.35%
· post 187.60
Closed
Nov 6 '26
Mkt cap
$289.1B
Revenue
—
Revenue
—
vs
Compare
Closed
Nov 6 '26
MRSH
Marsh & McLennan Companies, Inc.
vs
AZN
Astrazeneca PLC
204.94
▼
−2.14%
post 204.20
Price
186.20
▼
−0.35%
post 187.60
$97.4B
Mkt cap
$289.1B
Q3 FY26
$6.6B
Revenue
—
FY25
$26.1B
Revenue
—
Change
Change
MRSH
204.94
▼
−2.14%
vs
AZN
186.20
▼
−0.35%
Closed
Nov 6 '26